FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385055001: Tablet (basic dose form)

  • SNOMED CT Concept\Qualifier value\Basic dose form (basic dose form)\Solid dose form\A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition.

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1479317011 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3534602016 Tablet (basic dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3635452013 A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
1459233010 Tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1479317011 Tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1479317011 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2536656014 Tablets en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2536656014 Tablets en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2613089014 Tablet dose form (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2660323018 Tablet dose form (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2660323018 Tablet dose form (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2770896013 Tablet dose form en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2770896013 Tablet dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3534602016 Tablet (basic dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3635452013 A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
13111000188116 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
13111000188116 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Is a Type of drug preparation false Inferred relationship Existential restriction modifier (core metadata concept)
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Is a Oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Is a Solid dose form true Inferred relationship Existential restriction modifier (core metadata concept)
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Has state of matter (attribute) Solid (state of matter) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Amfepramone hydrochloride 25 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Naproxen sodium 375mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Naproxen sodium 500mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Protriptyline hydrochloride 10 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Protriptyline hydrochloride 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Amitriptyline hydrochloride 75 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Amitriptyline hydrochloride 150 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amitriptyline hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Labetalol hydrochloride 300 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely isosorbide dinitrate 2.5 milligram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Fluphenazine hydrochloride 10 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Propranolol hydrochloride 60 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Propranolol hydrochloride 20 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Sodium fluoride 550 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Sodium fluoride 2.21 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely sodium fluoride 500 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Sodium fluoride 1 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Sodium fluoride 250 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Phenylephrine hydrochloride 10 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely potassium citrate 1.08 gram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely potassium citrate 540 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyzine hydrochloride 100 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyzine hydrochloride 50 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Potassium chloride 10meq m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing potassium chloride 8 mEq/1 each oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Potassium chloride 750 mg10 meq tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely potassium chloride 750 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Potassium chloride 10 meq750 mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing potassium chloride 10 mEq/1 each oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely potassium chloride 1.5 gram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing potassium chloride 20 mEq/1 each oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely flecainide acetate 150 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely risperidone 250 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pimozide 1 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Olanzapine 20 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Olanzapine 15 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pramipexole dihydrochloride 500 microgram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Pramipexole dihydrochloride 125micrograms tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Pramipexole dihydrochloride 250micrograms tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pramipexole dihydrochloride 1.5 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Pramipexole dihydrochloride 1mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Nisoldipine 40mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely trandolapril 4 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Lisinopril 40 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Lisinopril 30 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing levonorgestrel 0.75 mg/1 each oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Acarbose 25 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Cabergoline 0.5mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Alprazolam 2 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Levetiracetam 750 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely terazosin 1 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Pindolol 10 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Didanosine 50 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Lorazepam 2 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Lorazepam 500 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glycopyrronium bromide 1 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Glycopyrronium bromide 2 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Glipizide 10 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely captopril 100 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Sevelamer hydrochloride 400 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely tolazamide 500 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely perphenazine 8 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Perphenazine 16 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely chlorpromazine hydrochloride 200 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Thyroid hormone 60 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely thyroid hormone 120 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Dipyridamole 75 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Dipyridamole 50 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Clonazepam 1 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely indapamide 1.25 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glibenclamide micronized 1.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Glibenclamide micronised 4.5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glibenclamide 6.3 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Glibenclamide micronised 6 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Glibenclamide micronised 3 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Glibenclamide 1.25 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Isoniazid 300 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Nadolol 120 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Nadolol 160 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely nadolol 20 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Nifedipine 90mg tablet (product) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Bumetanide 2 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely bumetanide 500 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Lamotrigine 150 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Simvastatin 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Haloperidol 1 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Haloperidol 2 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carteolol hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carteolol hydrochloride 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Dexamethasone 4 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely dexamethasone 750 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely oxandrolone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Estropipate 2.5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely salsalate 500 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Salsalate 750 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Phenazopyridine hydrochloride 100 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Phenazopyridine hydrochloride 200 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Amoxicillin 500 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Amoxicillin 400 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Erythromycin 500 mg gastro-resistant oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)

Start Previous Page 21 of 28 Next End

This concept is not in any reference sets

Back to Start